Editas Medicine (EDIT) Share-based Compensation Growth (3y) (2018 - 2025)
Editas Medicine (EDIT) Share-based Compensation Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 244.08% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -50.27% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -0.04% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 38.45% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -59.38% |
| Dec 31, 2024 | -9.86% |
| Sep 30, 2024 | 18.36% |
| Jun 30, 2024 | -146.13% |
| Mar 31, 2024 | -14.66% |
| Dec 31, 2023 | -59.56% |
| Sep 30, 2023 | -6.81% |
| Jun 30, 2023 | 146.07% |
| Mar 31, 2023 | -10.18% |
| Dec 31, 2022 | 37.01% |
| Sep 30, 2022 | -3.57% |
| Jun 30, 2022 | 185.97% |
| Mar 31, 2022 | 13.32% |
| Dec 31, 2021 | -10.70% |
| Sep 30, 2021 | 14.33% |
| Jun 30, 2021 | 13.26% |
| Mar 31, 2021 | 8.59% |
| Dec 31, 2020 | -18.03% |
| Sep 30, 2020 | -27.42% |
| Jun 30, 2020 | -68.14% |